TMO vs V: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
VS
Visa Inc. · Financial Services
$327.24
+27.8% upside to fair value
Grade A
High Quality
QuantHub Verdict
V has more upside to fair value
(+27.8%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
V |
| Current Price |
$464.61 |
$327.24 |
| Fair Value Estimate |
$498.27 |
$418.15 |
| Upside to Fair Value |
+7.2%
|
+27.8%
|
| Market Cap |
$172.7B |
$627.3B |
| Forward P/E |
25.2x
|
28.2x
|
| EV / EBITDA |
19.1x
|
22.6x
|
| Price / Sales |
3.8x
|
14.6x
|
| Price / FCF |
25.6x
|
29.6x
|
| Revenue Growth YoY |
+6.2%
|
+17.1%
|
| Gross Margin |
39.4%
|
81.3%
|
| Operating Margin |
17.8%
|
61.1%
|
| Return on Equity |
13.3%
|
58.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.91%
|
3.38%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Visa Inc. operates a global payments network that facilitates electronic funds transfers worldwide, primarily through credit and debit cards. The company benefits from a very strong and widening moat driven by its extensive global card network and acceptance infrastructure, supported by a shareholder-friendly capital allocation policy including high buybacks and dividends. Visa's business quality…
Accumulation Zones
| Metric |
TMO |
V |
| Zone Low |
$373.70 |
$313.61 |
| Zone High |
$423.53 |
$355.43 |
| In Buy Zone? |
No
|
Yes
|